Ceftazidime-250 mg Injection | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Ceftazidime-250 mg Injection
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Injection
Class: Third-Gen Cephalosporin
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Ceftazidime-250 mg Injection Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Ceftazidime-250 mg Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Ceftazidime-250 mg Injection is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Ceftazidime-250 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Same as Fectim-1g — moderate infections
Mechanism of Action
Ceftazidime is a third-generation cephalosporin with strong anti-Pseudomonas activity. Binds penicillin-binding proteins inhibiting cell wall synthesis. Particularly used in serious nosocomial gram-negative infections.
Dosage & Administration
- Variable based on weight and severity.
Side Effects
- Same as Fectim-125.
Contraindications
- Same as Fectim-125.
Storage
Store below 25 °C, protected from light.
PCD Pharma Franchise for Ceftazidime-250 mg Injection
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: Vial + Water
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Ceftazidime-250 mg Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Ceftazidime-250 mg Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Ceftazidime-250 mg Injection?
Trumac Healthcare is a WHO-GMP certified manufacturer of Ceftazidime-250 mg Injection in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Ceftazidime-250 mg Injection available for PCD pharma franchise on monopoly basis?
Yes. We offer Ceftazidime-250 mg Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Ceftazidime-250 mg Injection?
Available pack sizes include: Vial + Water.
What is the MRP / trade price for Ceftazidime-250 mg Injection?
MRPs range from ₹88 to ₹88 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Ceftazidime-250 mg Injection?